MOREHOUSE CCRE ADMINISTRATIVE CORE

这个子项目是许多研究子项目中利用 资源由NIH/NCRR资助的中心拨款提供。子项目和 调查员(PI)可能从NIH的另一个来源获得了主要资金， 并因此可以在其他清晰的条目中表示。列出的机构是 该中心不一定是调查人员的机构。 描述(由申请人提供)： 我们国家的生物医学体系的最终考验是它能否充分利用 美国多样化的人口，并关心我们社会中最脆弱的部分。健康方面的种族差异和少数族裔临床研究人员代表性不足的双刃剑问题是我们生物医学事业最明显的失败之一。莫尔豪斯医学院(MSM)独一无二地准备在纠正这些问题方面发挥领导作用，并为实现NIH路线图的计划做出贡献，该计划旨在重新设计面向21世纪的临床研究企业。MSM总裁David Satcher博士(美国第16任卫生局局长)致力于将MSM打造为解决健康差距负担的卓越研究中心之一的目标。拟议的CCRE研究计划将是该机构战略计划的关键要素，以继续成功地扩大我们的翻译和以患者为导向的研究组合。该计划的主要目标是建立一个研究基础设施，以促进初级临床研究人员队伍的成功发展，成为临床研究企业的未来领导者。这一CCRE计划将建立在MSM最近在增强其研究组合方面的成功轨迹的基础上，通过追求以下具体目标： 目的一、建立一个组织框架，以促进合作、跨学科的临床研究方法，使MSM科学界的所有人员都参与进来，并为MSM初级教员的发展创造一个有益的研究环境。 目的II.建立一个机构范围的机制，以招募和指导一大批有才华的年轻教师，他们将在MSM开发成功的翻译和临床研究项目。 瞄准111号。招聘一名‘磁铁调查员’，持续领导CCRE项目，进一步提高MSM的研究能力，并扩大资深临床医生-科学家导师的临界群体。 目的IV.通过在转化性和以患者为导向的研究中不断纳入新的使能技术，建立一个充满活力的、协作的研究基础设施，以支持临床研究的持续创新过程。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. DESCRIPTION (provided by applicant): The ultimate test our nation's biomedical system is its capacity to draw upon the full breadth of talent of America's diverse population and care for the most vulnerable elements of our society. The dual-edged problems of ethnic disparities in health and the under-representation of minority clinical investigators are among the most glaring failures of our biomedical enterprise. The Morehouse School of Medicine (MSM) is uniquely poised to provide leadership in redressing these problems and contribute to the fulfillment of the NIH Roadmap's plan to re-engineer the clinical research enterprise for the 21st century. MSM's President, Dr. David Satcher (the 16th US Surgeon General), is committed to the goal of establishing the MSM as one of the preeminent centers of excellence in research that addresses the burden of health disparities. The proposed CCRE research program will be a critical element of the institution's strategic plan to continue the successful expansion of our translational and patient-oriented research portfolio. The major objective of this program focuses on establishing a research infrastructure that will foster the successful development of a cadre of junior clinical investigators into future leaders of the clinical research enterprise. This CCRE program will build upon MSM's recent trajectory of success in enhancing its research portfolio by pursuing the following specific aims: Aim I. To establish an organizational framework for promoting a collaborative, inter-disciplinary approach to clinical investigation that engages the full breadth of the MSM scientific community and creates a nurturing research environment for the development of MSM's junior faculty. Aim II. To establish an institution-wide mechanism to recruit and mentor a critical mass of talented young faculty who will develop successful translational and clinical research programs at MSM. Aim 111. To recruit a 'magnet investigator' who will provide ongoing leadership of the CCRE program, further enhance MSM's research capacity and expand the critical mass of senior clinician-scientist mentors. Aim IV. To establish a vibrant, collaborative research infrastructure that supports a continual process of innovation in clinical investigation by the ongoing incorporation of new enabling technologies in translational and patient-oriented research.